Travere Therapeutics, Inc.
TVTX
60 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2025 | Feb 6 9:21 PM | ROY D BAYNES | Proposed Sale | 10,000 | $22.00 | $220.0K | — | View → |
| Feb 4, 2025 | Feb 4 9:11 PM | JULA INRIG | Proposed Sale | 1,066 | $20.11 | $21.4K | — | View → |
| Feb 3, 2025 | Feb 4 1:47 AM | Peter Heerma | Proposed Sale | 5,166 | $20.12 | $103.9K | — | View → |
| Feb 3, 2025 | Feb 4 1:46 AM | Christopher Cline | Proposed Sale | 5,192 | $20.12 | $104.5K | — | View → |
| Feb 3, 2025 | Feb 4 1:41 AM | Sandra Calvin | Proposed Sale | 3,348 | $20.12 | $67.4K | — | View → |
| Feb 3, 2025 | Feb 4 1:40 AM | Jula Inrig | Proposed Sale | 4,207 | $20.12 | $84.6K | — | View → |
| Feb 3, 2025 | Feb 3 5:26 PM | REED ELIZABETH E | Proposed Sale | 8,951 | $19.78 | $177.1K | — | View → |
| Feb 3, 2025 | Feb 3 4:22 PM | Dube Eric M | Proposed Sale | 50,691 | $19.78 | $1.0M | — | View → |
| Feb 3, 2025 | Feb 3 4:11 PM | ROTE WILLIAM E. | Proposed Sale | 8,951 | $19.78 | $177.1K | — | View → |
| Jan 23, 2025 | Jan 23 9:14 PM | ROY D BAYNES | Proposed Sale | 16,000 | $20.00 | $320.0K | — | View → |
| Jan 22, 2025 | Jan 22 3:34 PM | Dube Eric M | Proposed Sale | 10,736 | $19.46 | $208.9K | — | View → |
| Jan 22, 2025 | Jan 22 3:18 PM | REED ELIZABETH E | Proposed Sale | 2,437 | $19.46 | $47.4K | — | View → |
| Jan 22, 2025 | Jan 22 2:36 PM | ROTE WILLIAM E. | Proposed Sale | 2,437 | $19.46 | $47.4K | — | View → |
| Dec 26, 2024 | Dec 26 9:13 PM | SANDRA CALVIN | Proposed Sale | 15,000 | $17.22 | $258.3K | — | View → |
| Nov 25, 2024 | Nov 25 10:59 PM | Calvin Sandra | Proposed Sale | 12,090 | $18.30 | $221.3K | — | View → |
| Oct 4, 2024 | Oct 4 8:21 PM | GARY A LYONS | Proposed Sale | 40,000 | $13.65 | $546.0K | — | View → |
| Sep 30, 2024 | Sep 30 8:22 PM | JEFFREY MECKLER | Proposed Sale | 40,000 | $14.06 | $562.3K | — | View → |
| Sep 11, 2024 | Sep 11 10:29 PM | Calvin Sandra | Proposed Sale | 15,000 | $14.80 | $222.0K | — | View → |
| Sep 9, 2024 | Sep 9 2:54 PM | REED ELIZABETH E | Proposed Sale | 4,387 | $11.52 | $50.5K | — | View → |
| Sep 9, 2024 | Sep 9 2:35 PM | ROTE WILLIAM E. | Proposed Sale | 4,387 | $11.52 | $50.5K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | May 21 9:00 PM | John A OrwinDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Meckler Jeffrey ADirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | LYONS GARY ADirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Timothy CoughlinDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Suzanne Louise BruhnDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Roy D. BaynesDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 5, 2026 | May 7 12:00 AM | Roy D. BaynesDirector | Option Exercise | 4,500 | $18.27 | 0(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Meckler Jeffrey ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| May 4, 2026 | May 7 12:00 AM | William E. RoteChief Research Officer | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | William E. RoteChief Research Officer | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 24,250 | $17.96 | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Option Exercise | 24,250 | $22.40 | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 22,500 | — | 22,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 45,000 | — | 45,000(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |